Der Hautarzt 2009-05-01

[Bufexamac-induced pigmented purpuric eruption].

K Waltermann, W Ch Marsch, B Kreft

Index: Hautarzt 60(5) , 424-7, (2009)

Full Text: HTML

Abstract

We report on a case of a bufexamac-induced allergic contact dermatitis with hematogenous dissemination presenting with the clinical and histological picture of a pigmented purpuric eruption. To our knowledge this is the first report on a bufexamac-induced pigmented purpuric dermatosis. It represents a further example of the clinical variety of cutaneous side-effects caused by bufexamac.

Related Compounds

Related Articles:

Erythema-multiforme-like, urticarial papular and plaque eruptions from bufexamac: report of 4 cases.

2015-02-11

[Contact Dermatitis 31(2) , 97-101, (1994)]

[A severe epicutaneous test reaction to the bufexamac in a hemorrhoidal therapeutic preparation].

1999-10-08

[Dtsch. Med. Wochenschr. 124(40) , 1168-70, (1999)]

[A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].

2005-12-16

[Dtsch. Med. Wochenschr. 130(50) , 2881-6, (2005)]

In vitro photobiochemical characterization of sulfobutylether-β-cyclodextrin formulation of bufexamac.

2011-06-01

[J. Pharm. Biomed. Anal. 55(3) , 591-6, (2011)]

Examinations of the antioxidative properties of the topically administered drug bufexamac reveal new insights into its mechanism of action.

2003-10-01

[J. Pharm. Pharmacol. 55(10) , 1379-88, (2003)]

More Articles...